Team, Visitors, External Collaborators
Overall Objectives
Research Program
Application Domains
Highlights of the Year
New Software and Platforms
New Results
Bilateral Contracts and Grants with Industry
Partnerships and Cooperations
XML PDF e-pub
PDF e-Pub

Section: Partnerships and Cooperations

European Initiatives

FP7 & H2020 Projects

The member of SISTM Team are involved in EHVA (European HIV Vaccine Alliance):

Collaborations in European Programs, Except FP7 & H2020

The members of SISTM are also involved in Innovative Medicine Initiative 2 (IMI2) projects which are all under the IMI Ebola+ program that was launched in response to the Ebola virus disease outbreak of 2014. SISTM is active in 3 projects which are all in collaboration with Janssen Vaccines & Preventions B.V. The overall aim of the EBOVAC program is to assess the safety, immunogenicity and efficacy of a novel 2-dose Ad26 + MVA prophylactic vaccine regimen against Ebola Virus Disease. In this context, the 3 projects develop as follows:

Collaborations with Major European Organizations